JPC
BSX icon

Jabodon PT Co’s Boston Scientific BSX Stock Holding History

Jabodon PT Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-75,251
Closed -$2.91M – 14
2021
Q1 		$2.91M Buy
+75,251
New +$2.85M 1.75% 17
2020
Q3 		– Sell
-77,374
Closed -$2.72M – 30
2020
Q2 		$2.72M Buy
+77,374
New +$2.79M 0.77% 11

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Jabodon PT Co's BSX Position: Q2 2021 in Review

Jabodon PT Co sold out of Boston Scientific (BSX) in Q2 2021, closing a stake of 75,251 shares — an estimated $2.91M sold.

Jabodon PT Co first reported a position in BSX in Q2 2020 and held it in 2 quarters. The position peaked at $2.91M in Q1 2021. 867 funds tracked by Wall St. Rank hold BSX as of Q2 2021.

  • Jabodon PT Co reported no remaining Boston Scientific position as of Q2 2021 after selling out during the quarter.
  • Jabodon PT Co sold 75,251 Boston Scientific shares in Q2 2021, an estimated $2.91M.
  • Jabodon PT Co first reported a position in Boston Scientific in Q2 2020 and held it in 2 quarters.
  • Jabodon PT Co's Boston Scientific position peaked at $2.91M in Q1 2021.
  • 867 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2021.

Based on Jabodon PT Co's 13F filing for Q2 2021, filed 6 Aug 2021.